Our Pipeline
Advancing a Robust Pipeline of Transformative Therapies
Our pipeline reflects a focused approach to developing next-generation treatments across key therapeutic areas, supported by structured research and early-stage development programs.
Program
Indication
Therapeutic Approach
Discovery
Optimization
Preclinical
IND-Enabling
Phase 1
New Stage
New Stage
ANTT-DM-201
Type 2 Diabetes
Peptide-Based Therapy
ANTT-ON-304
Colorectal Cancer
Targeted Biologic
ANTT-RG-102
Blood Regeneration
Cellular Regenerative Therapy
ANTT-RS-118
Chronic Respiratory Conditions
Intranasal Delivery Platform
PROG-101
Disease Target
Therapy Modality
PROG-101
Disease Target
Therapy Modality